Aging erythrocyte membranes as biomimetic nanometer carriers of liver-targeting chromium poisoning treatment

• Published in: Drug delivery Vol. 28; no. 1; pp. 1455 - 1465
• Main Authors: Yao, Qing, Yang, Guobao, Wang, Hao, Liu, Jingzhou, Zheng, Jinpeng, Lv, Bai, Yang, Meiyan, Yang, Yang, Gao, Chunsheng, Guo, Yongxue
• Format: Journal Article
• Language: English
• Published: Philadelphia Taylor & Francis 01.01.2021; Taylor & Francis Ltd; Taylor & Francis Group
• Subjects: Aging; Aging erythrocyte membranes; bionic nanocarrier; chromium poisoning; dimercaptosuccinic acid; Drug delivery systems; Liver; liver-targeted; Nanoparticles; Poisoning
• ISSN: 1071-7544; 1521-0464
• DOI: 10.1080/10717544.2021.1949075

Chromium poisoning has become one of the most common heavy metal poisoning occupational diseases with high morbidity and mortality. However, most antidotes detoxify the whole body and are highly toxic. To achieve hepato-targeted chromium poisoning detoxification, a novel hepato-targeted strategy was developed using aging erythrocyte membranes (AEMs) as biomimetic material coated with a dimercaptosuccinic acid (DMSA) nanostructured lipid carrier to construct a biomimetic nano-drug delivery system. The particle size, potential, drug loading, encapsulation rate, in vitro release, and stability of the nanoparticles (NPs) were characterized. Confocal microscopy and flow cytometry showed that the prepared NPs could be phagocytized by RAW264.7 macrophage cells. The efficacy of AEM-DMSA-NPs for targeted liver detoxification was evaluated by in vitro MTT analysis and an in vivo model of chromium poisoning. The results showed that the NPs could safely and efficiently achieve targeted liver chromium poisoning detoxification. All the results indicated that the biomimetic nano-drug delivery system mediated by aging erythrocyte membranes and containing DMSA nanoparticles could be used as a novel therapeutic drug delivery system potentially targeting liver detoxification.